The production and extracellular release of a recombinant Herpes Simplex Virus (type 2) from monolayers of infected complementing Vero cells (CR2) are addressed. Growth and virus production conditions are identified that provide adequate virus titers with cell seeding densities and viral multiplicit
The affinity adsorptive recovery of an infectious Herpes Simplex Virus vaccine
โ Scribed by R. S. O'Keeffe; M. D. Johnston; N. K. H. Slater
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 642 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0006-3592
No coin nor oath required. For personal study only.
โฆ Synopsis
The chromatographic purification of a recombinant Herpes Simplex Virus (type 2) from salt-and heparin-released harvests of infected complementing Vero (CR2) cells is addressed. Functionalized matrices and process operating conditions are identified that provide adequate virus titres in eluates that are significantly reduced in CR2 cell protein and DNA and possess a low level of HSV-2 protein. Virus from diluted salt-released harvests (0.14 M NaCl) was not appreciably adsorbed onto either heparin-Sepharose or Cellufine-heparin matrices but was virtually completely adsorbed onto Cellufine-sulfate and heparin-HP matrices. Virus was recovered by either a linear salt gradient elution (0.14-2 M NaCl) or by a single-step elution with 1.5 M NaCl in phosphate buffer. Recoveries of infectious virus with step elution were 21% and 89%, respectively, for these matrices. Virus from undiluted salt-released harvest (0.8 M NaCl) was substantially adsorbed onto Cellufine-sulfate gel (44% adsorption) and completely adsorbed onto heparin-HP matrices. This virus was recovered with high yield by either gradient or step elution with phosphate-buffered saline. Finally, heparin-harvested virus was fed directly to these matrices and quantitatively adsorbed. The virus could be completely recovered from the heparin-HP matrix with 1.5 M NaCl buffer to provide a purified preparation containing only 0.05 pg protein/pfu and 1.2 ร 10 -4 pg DNA/pfu.
๐ SIMILAR VOLUMES
## Abstract The use of mammalian cells as substrates for the production of various vaccines is a timeโhonored procedure. With the advent of recombinant DNA technology, various investigators soon realized that these techniques could be applied to mammalian cells to convert them to reliable, safe pro
Hepatitis is a rare complication of herpes simplex virus (HSV), often leading to acute liver failure (ALF), liver transplantation (LT), and/or death. Our aim was to identify variables associated with either survival or progression (death/LT), based on an analysis of cases in the literature and our i
## Abstract ## Background Cereproยฎ (sitimagene ceradenovec) is an adenoviral vector containing herpes simplex virus thymidine kinase gene (HSVโtk), which is being developed for the treatment of highโgrade glioma with oral ganciclovir (GCV). The nonclinical safety and biodistribution of Cereproยฎ we